| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock, $0.0001 par value | 3,275,616 | $5,670,746 | $1.73 | 13 Jun 2024 | By Funds |
| Icosavax, Inc. | Director | Common Stock | 256,783 | $4,024,432 | $15.67 | 02 Aug 2021 | Indirect |
| Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40,000 | 26 May 2022 | Direct | ||
| Corvus Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15,000 | 13 Jun 2024 | Direct | ||
| Icosavax, Inc. | Director | Series A-1 Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Icosavax, Inc. | Director | Series B-1 Preferred Stock | 0 | 02 Aug 2021 | Indirect |